De Clercq K - Search Results

1

Foot-and-mouth disease virus serotype SAT1 in cattle, Nigeria.

Ehizibolo DO, Haegeman A, De Vleeschauwer AR, Umoh JU, Kazeem HM, Okolocha EC, Van Borm S, De Clercq K. Ehizibolo DO, et al. Among authors: de vleeschauwer ar, de clercq k. Transbound Emerg Dis. 2017 Jun;64(3):683-690. doi: 10.1111/tbed.12629. Epub 2017 Feb 21. Transbound Emerg Dis. 2017. PMID: 28224715

2

Rapid and sensitive polymerase chain reaction based detection and typing of foot-and-mouth disease virus in clinical samples and cell culture isolates, combined with a simultaneous differentiation with other genomically and/or symptomatically related viruses.

Vangrysperre W, De Clercq K. Vangrysperre W, et al. Among authors: de clercq k. Arch Virol. 1996;141(2):331-44. doi: 10.1007/BF01718403. Arch Virol. 1996. PMID: 8634024

3

Implementation of quality assurance in national foot and mouth disease laboratories, based on the guidelines of the Office International des Epizooties.

De Clercq K. De Clercq K. Rev Sci Tech. 1998 Dec;17(3):786-95. doi: 10.20506/rst.17.3.1141. Rev Sci Tech. 1998. PMID: 9850551 Free article.

4

Extending the foot-and-mouth disease module to the control of other diseases.

De Clercq K, Goris N. De Clercq K, et al. Dev Biol (Basel). 2004;119:333-40. Dev Biol (Basel). 2004. PMID: 15742644 Review.

5

Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.

Goris N, De Clercq K. Goris N, et al. Among authors: de clercq k. Rev Sci Tech. 2005 Dec;24(3):995-1004. Rev Sci Tech. 2005. PMID: 16642770 Free article.

6

2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus.

Goris N, De Palma A, Toussaint JF, Musch I, Neyts J, De Clercq K. Goris N, et al. Among authors: de palma a, de clercq k. Antiviral Res. 2007 Mar;73(3):161-8. doi: 10.1016/j.antiviral.2006.09.007. Epub 2006 Oct 10. Antiviral Res. 2007. PMID: 17055073

7

European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences.

Goris N, Merkelbach-Peters P, Diev VI, Verloo D, Zakharov VM, Kraft HP, De Clercq K. Goris N, et al. Among authors: de clercq k. Vaccine. 2007 Apr 30;25(17):3373-9. doi: 10.1016/j.vaccine.2006.12.049. Epub 2007 Jan 16. Vaccine. 2007. PMID: 17227691

8

Bluetongue in Belgium, 2006.

Toussaint JF, Sailleau C, Mast J, Houdart P, Czaplicki G, Demeestere L, VandenBussche F, van Dessel W, Goris N, Bréard E, Bounaadja L, Etienne T, Zientara S, De Clercq K. Toussaint JF, et al. Among authors: de clercq k. Emerg Infect Dis. 2007 Apr;13(4):614-6. doi: 10.3201/eid1304.061136. Emerg Infect Dis. 2007. PMID: 17553280 Free PMC article.

9

Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field.

Goris N, Praet N, Sammin D, Yadin H, Paton D, Brocchi E, Berkvens D, De Clercq K. Goris N, et al. Among authors: de clercq k. Vaccine. 2007 Oct 10;25(41):7177-96. doi: 10.1016/j.vaccine.2007.07.023. Epub 2007 Aug 2. Vaccine. 2007. PMID: 17709157

10

Assessment of the diagnostic potential of immuno-RCA in 96-well ELISA plates for foot-and-mouth disease virus.

Van Dessel W, Vandenbussche F, Staes M, Goris N, De Clercq K. Van Dessel W, et al. Among authors: de clercq k. J Virol Methods. 2008 Jan;147(1):151-6. doi: 10.1016/j.jviromet.2007.08.020. Epub 2007 Oct 25. J Virol Methods. 2008. PMID: 17913251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters